139 related articles for article (PubMed ID: 9424277)
1. [The application of intraarterial chemotherapy for the treatment of osteogenic sarcoma in children].
Glukhovskaia IIu
Klin Khir; 1997; (2):12-4. PubMed ID: 9424277
[TBL] [Abstract][Full Text] [Related]
2. [Osteogenic sarcoma of the limbs: value of intra-arterial chemotherapy before surgery. Preliminary results].
Pouillart P; Palangie T; Dorval T; Berthau N; Daugu M; Coutant M; Forest M; Courpied JP; Tomeno B
Pathol Biol (Paris); 1992 Nov; 39(9):952-3. PubMed ID: 1538949
[No Abstract] [Full Text] [Related]
3. [Therapeutic results of patients with osteogenic sarcoma by the protocol COSS 77 (author's transl)].
Prindull G; Poppe H; Jentsch E; Schauer A
Unfallheilkunde; 1981 Dec; 84(12):524-5. PubMed ID: 6948465
[No Abstract] [Full Text] [Related]
4. [Neoadjuvant chemotherapy of osteosarcoma. Preliminary results of the cooperative COSS-86 osteosarcoma study].
Bieling P; Bielack S; Delling G; Jürgens H; Kotz R; Dose C; Astheimer H; Exner G; Gadner H; Graf N
Klin Padiatr; 1991; 203(4):220-30. PubMed ID: 1942929
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of osteogenic sarcoma].
Tateishi A
Gan No Rinsho; 1989 Jan; Spec No():483-90. PubMed ID: 2915497
[No Abstract] [Full Text] [Related]
6. Marginal excision for osteosarcoma with caffeine assisted chemotherapy.
Tsuchiya H; Tomita K; Mori Y; Asada N; Yamamoto N
Clin Orthop Relat Res; 1999 Jan; (358):27-35. PubMed ID: 9973973
[TBL] [Abstract][Full Text] [Related]
7. [Preoperative and postoperative chemotherapy of osteogenic sarcoma of the limbs in children].
Muñoz Villa A; Ocete G; Aymerich ML; Maldonado S; Otheo E; Calvo M; Amaya J
Med Clin (Barc); 1996 Jun; 107(5):161-4. PubMed ID: 8758673
[TBL] [Abstract][Full Text] [Related]
8. The importance of doxorubicin and methotrexate dose intensity in the chemotherapy of osteosarcoma.
Kawai A; Sugihara S; Kunisada T; Hamada M; Inoue H
Arch Orthop Trauma Surg; 1996; 115(2):68-70. PubMed ID: 9063854
[TBL] [Abstract][Full Text] [Related]
9. [Progress and stagnation in chemotherapy protocols for primary osteosarcoma].
Delépine N; Alkallaf S; Cornille H; Markowska B; Delépine G
Ann Med Interne (Paris); 2003 Feb; 154(1):12-24. PubMed ID: 12746655
[TBL] [Abstract][Full Text] [Related]
10. [Bone tumors in children. Current trends in therapy].
Zucker JM; Pacquement H; Quintana E; Michon J; Doz F
Pathol Biol (Paris); 1992 Nov; 39(9):948-9. PubMed ID: 1538946
[No Abstract] [Full Text] [Related]
11. Methotrexate, doxorubicin, and cisplatinum regimen is still the preferred option for osteosarcoma chemotherapy: A meta-analysis and clinical observation.
Yu D; Zhang S; Feng A; Xu D; Zhu Q; Mao Y; Zhao Y; Lv Y; Han C; Liu R; Tian Y
Medicine (Baltimore); 2019 May; 98(19):e15582. PubMed ID: 31083238
[TBL] [Abstract][Full Text] [Related]
12. Intraarterial Cisplatin and intravenous adriamycin in nonmetastatic osteosarcoma of the extremities: a single institution experience in Taiwan.
Chiu TJ; Wang JW; Chen YJ; Tang Y; Huang CH
Chang Gung Med J; 2009; 32(1):72-80. PubMed ID: 19292942
[TBL] [Abstract][Full Text] [Related]
13. Progression of osteosarcoma after high-dose methotrexate: over-rescue by folinic acid.
Cohen IJ
Pediatr Hematol Oncol; 2003 Dec; 20(8):579-81. PubMed ID: 14578026
[TBL] [Abstract][Full Text] [Related]
14. The effect of intra-arterial versus intravenous cisplatinum in the neoadjuvant treatment of osteosarcoma of the limbs: the experience at the Rizzoli Institute.
Bacci G; Ferrari S; Forni C; Mercuri M; Picci P; Bertoni F; Capanna R; Manfrini M; Donati D; Brach Del Prever A; Baldini N
Chir Organi Mov; 1996; 81(4):369-82. PubMed ID: 9147928
[TBL] [Abstract][Full Text] [Related]
15. Pediatric osteosarcoma: treatment of the primary tumor with intraarterial cis-diamminedichloroplatinum-II (CDP)--advantages, disadvantages, and controversial issues.
Jaffe N
Cancer Treat Res; 1993; 62():75-84. PubMed ID: 8096762
[TBL] [Abstract][Full Text] [Related]
16. Chemosensitivity testing with tumor colony-forming assay for human osteosarcoma.
Tomita K; Yokogawa A
Jpn J Antibiot; 1986 May; 39(5):1228-33. PubMed ID: 3463773
[TBL] [Abstract][Full Text] [Related]
17. Patient-derived osteosarcoma cells are resistant to methotrexate.
Dos Santos Cavalcanti A; Meohas W; Ribeiro GO; de Sá Lopes AC; Gholamin S; Razavi M; Hanae Kasai Brunswick T; Avan A; Matheus Guimarães JA; Leite Duarte ME; Kahn SA
PLoS One; 2017; 12(9):e0184891. PubMed ID: 28934267
[TBL] [Abstract][Full Text] [Related]
18. A comparison of methods of loco-regional chemotherapy combined with systemic chemotherapy as neo-adjuvant treatment of osteosarcoma of the extremity.
Bacci G; Ferrari S; Tienghi A; Bertoni F; Mercuri M; Longhi A; Fiorentini G; Forni C; Bacchini P; Rimondini S; De Giorgi U; Picci P
Eur J Surg Oncol; 2001 Feb; 27(1):98-104. PubMed ID: 11237499
[TBL] [Abstract][Full Text] [Related]
19. Regional chemotherapy for osteosarcoma.
Benjamin RS
Semin Oncol; 1989 Aug; 16(4):323-7. PubMed ID: 2667147
[No Abstract] [Full Text] [Related]
20. Intensified chemotherapy with ifosfamide (IFO) and influence of intraarterial (i.a.) versus intravenous (i.v.) infusion of cisplatinum (DDP). Preliminary results.
Winkler K; Bielack S; Delling G; Salzer-Kuntschik M; Purfürst C; Heise U; Jürgens H; Kotz R; Gadner H; Ritter J
Chir Organi Mov; 1990; 75(1 Suppl):54-6. PubMed ID: 2249558
[No Abstract] [Full Text] [Related]
[Next] [New Search]
